References
Langa KM, Levine DA (2014) The diagnosis and management of mild cognitive impairment: a clinical review. JAMA 312:2551–2561
Paterniti I, Cordaro M, Campolo M et al (2014) Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer’s disease models: the control of neuroinflammation. CNS Neurol Disord Drug Targets 13:1530–1541
Calabrò RS, Bramanti P (2013) Occipital neuralgia responding to palmitoylethanolamide. Headache. doi:10.1111/head.12136
Mattace Raso G, Russo R, Calignano A et al (2014) Palmitoylethanolamide in CNS health and disease. Pharmacol Res 86:32–41
Ahmad A, Crupi R, Impellizzeri D et al (2012) Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice. Brain Behav Immun 26:1310–1321
Bravo G, Hebert R (1997) Age- and education-specific reference values for the Mini-Mental and modified Mini-Mental State Examinations derived from a non-demented elderly population. Int J Geriatr Psychiatry 12:1008–1018
Nasreddine ZS, Phillips NA, Bédirian V et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–969
Horner MD, Teichner G, Kortte KB et al (2002) Construct validity of the Babcock Story Recall Test. Appl Neuropsychol 9:114–116
Bezdicek O, Stepankova H, Moták L et al (2014) Czech version of Rey Auditory Verbal Learning test: normative data. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 21:693–721
Davous P, Lamour Y, Debrand E et al (1987) A comparative evaluation of the short orientation memory concentration test of cognitive impairment. JNNP 50:1312–1317
Tombaugh TN (2004) Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol 19:203–214
Luo L, Luk G, Bialystok E (2010) Effect of language proficiency and executive control on verbal fluency performance in bilinguals. Cognition 114:29–41
Pagani M, Salmaso D, Ramström C et al (2001) Mapping pathological 99mTc-HMPAO uptake in Alzheimer’s disease and frontal lobe dementia with SPECT. Dement Geriatr Cogn Disord 12:177–184
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have neither conflict of interests nor financial support to declare.
Statement of human and animal rights
All procedure followed were in accordance with the ethical standards of the responsible committee on human experimentation, and with the Helsinki Declaration of 1976, as revised in 2008.
Informed consent
Informed consent was obtained from the patient.
Rights and permissions
About this article
Cite this article
Calabrò, R.S., Naro, A., De Luca, R. et al. PEALut efficacy in mild cognitive impairment: evidence from a SPECT case study!. Aging Clin Exp Res 28, 1279–1282 (2016). https://doi.org/10.1007/s40520-016-0533-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-016-0533-6